The research group led by Benjamin Ineichen is dedicated to enhancing preclinical and clinical neuroscience through evidence-based research. Their mission is to equip neuroscientists with state-of-the-art automated tools and education for evidence synthesis. This commitment aims to accelerate the development of therapies for neurological and psychiatric conditions and to advance animal welfare in the field.